<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6238">
  <stage>Registered</stage>
  <submitdate>29/12/2016</submitdate>
  <approvaldate>29/12/2016</approvaldate>
  <nctid>NCT03011398</nctid>
  <trial_identification>
    <studytitle>A Clinical Registry of Orthobiologics Procedures</studytitle>
    <scientifictitle>Interventional Orthopedics Foundation Patient Registry Database-A Clinical Registry of Orthobiologics Procedures</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>RSI2015-REG01</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Orthopedic Disorder</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Orthobiologic Procedures

Treatment: surgery: Orthobiologic Procedures
To observe the improvement in subject-reported clinical outcomes for percutaneous orthopedic procedures used to treat musculoskeletal disorders.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in Percent Improvement</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Pain Scale</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>International Knee Documentation Committee form</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Lower Extremity Function Scale</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Disabilities of the Arm, Shoulder and Hand form</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Oxford Hip Score</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Functional Rating Index</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Complications</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse Events</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of Re-injections to treated area - number of additional injections to treated area such as platelet rich plasma or stem cell treatment</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Number of Surgical Interventions to treated area</outcome>
      <timepoint>1 month, 3 months, 6 months, 12 months, 18 months and annually 2-20 years post treatment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Candidates must meet ALL of the following:

               1. Voluntary signature of the IRB approved Informed Consents,

               2. Treated with a Regenexx procedure

               3. Have a musculoskeletal condition appropriate for the procedure such as
                  osteoarthritis or internal joint derangement; ligament or tendon injury;
                  intervertebral disc degeneration; protrusion, extrusion, or annular tear; muscle
                  tear</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria />
  </eligibility>
  <trial_design>
    <studytype>Observational [Patient Registry]</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/02/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50000</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/02/2036</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Nepean Specialist Sports Medicine - Kingswood</hospital>
    <postcode>2747 - Kingswood</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arizona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Colorado</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Florida</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Illinois</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Iowa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Kentucky</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Louisiana</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Maryland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Minnesota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New Jersey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Oklahoma</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Oregon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Pennsylvania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Utah</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Vermont</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Virginia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Telangana</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Interventional Orthopedics Foundation</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Commercial sector/Industry</othercollaboratortype>
      <othercollaboratorname>Regenerative Sciences, LLC</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the Registry study is to observe the improvement in subject-reported clinical
      outcomes for percutaneous orthopedic procedures for treatment of musculoskeletal disorders.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT03011398</trialwebsite>
    <publication>Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2010 Mar;5(1):81-93.
Centeno CJ, Schultz JR, Cheever M, Freeman M, Faulkner S, Robinson B, Hanson R. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2011 Dec;6(4):368-78.
Bain BJ. Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004. Haematologica. 2006 Sep;91(9):1293-4.
Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010 Jun;38(6):1110-6. doi: 10.1177/0363546509359067. Epub 2010 Apr 14.
Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T, Nawata M, Tensho K, Kato H, Uematsu K, Kuroda R, Kurosaka M, Yoshiya S, Hattori K, Ohgushi H. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2011 Feb;5(2):146-50. doi: 10.1002/term.299.
</publication>
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Christopher Centeno, MD</name>
      <address>Regenerative Sciences, LLC and Centeno-Schultz Clinic</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>